Hutch News

Hutch News

Stories tagged 'Christopher J Kemp'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 19, 2017

Dr. Ruth Etzioni, a Fred Hutch biostatistician, has received a five-year National Institutes of Health grant to advance the science of cancer surveillance by developing, validating and deploying a scalable, automated approach for identifying cancer recurrence.

View story >


Finding ways to deliver on the promise of precision oncology

‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients

March 31, 2017 | By Rachel Tompa / Fred Hutch News Service

Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.

View story >


Researchers closer to early lung cancer detection

Sam Hanash leads discovery of blood proteins associated with early development of lung cancer; findings hold promise of a blood test for screening, diagnosis

Sept. 19, 2011 | By Kristen Woodward

A Fred Hutchinson Cancer Research Center team has discovered proteins in the blood that are associated with early lung cancer development in mice and humans. The advance brings the reality of a blood test for the early detection and diagnosis of lung cancer a step closer.

View story >


Systems biology may improve early detection of aggressive breast cancer

Chris Kemp and Sam Hanash’s study is the first to examine how blood protein levels change as cancer develops—long before the disease is clinically detectable

Aug. 1, 2011 | By Kristen Woodward

Fred Hutchinosn Cancer Research Center researchers for the first time have identified a set of proteins in the blood that change in abundance long before aggressive breast cancer is clinically detectable.

View story >


Improving biomarker development to improve patient outcomes

Amanda Paulovich and colleagues find proof-of-concept study of biomarker development provides roadmap for similar approach in humans

June 20, 2011 | By Kristen Woodward

Fred Hutchinson Cancer Research Center researchers have demonstrated in mice that the performance of a novel biomarker-development pipeline using targeted mass spectrometry is robust enough to support the use of an analogous approach in humans. The findings, by principal investigator Dr. Amanda Paulovich of the Clinical Research Division, were published online June 19 in Nature Biotechnology.

View story >


The melding of diverse minds around proteomics initiative

Paulovich Lab harnesses specialists from a variety of fields for contributions to $104 million National Cancer Institute network

Feb. 1, 2007 | By STEPHANIE CARTIER

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.